China Pharma Holdings (CPHI) Prepaid Assets (2014 - 2026)
China Pharma Holdings (CPHI) posted Prepaid Assets of $74279.0 for Q1 2026, down 9.82% on a QoQ basis from $82368.0 in Q4 2025, and down 9.93% year-over-year from $82469.0 in Q1 2025.
China Pharma Holdings (CPHI) Prepaid Assets (2014 - 2026) Analysis & Trends
China Pharma Holdings' Prepaid Assets history runs 13 years deep, the most recent figure standing at $74279.0 for Q1 2026.
- Quarterly Prepaid Assets fell 9.93% year-over-year to $74279.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $74279.0 (down 9.93% YoY) and the FY2025 annual result came in at $82368.0, up 1.28% from the prior year.
- Prepaid Assets was $74279.0 for Q1 2026 at China Pharma Holdings, down from $82368.0 in the prior quarter.
- Across five years, Prepaid Assets topped out at $268498.0 in Q3 2023 and bottomed at $71788.0 in Q1 2022.
- A 5-year average of $107702.9 and a median of $87269.0 in 2022 frame the typical range for Prepaid Assets.
- Annual changes were most pronounced in 2023 — Prepaid Assets surged 207.67% — and 2025, when it tumbled 59.57%.
- China Pharma Holdings' Prepaid Assets stood at $77697.0 in 2022, then soared by 41.91% to $110258.0 in 2023, then declined by 26.24% to $81328.0 in 2024, then gained by 1.28% to $82368.0 in 2025, then fell by 9.82% to $74279.0 in 2026.
- Business Quant data shows CPHI's Prepaid Assets at $74279.0 in Q1 2026, $82368.0 in Q4 2025, and $75627.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | China Pharma Holdings | 629,344.02 | 460,870.02 | 285,487.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 74,279.00 |
| Dec 31, 2025 | 82,368.00 |
| Sep 30, 2025 | 75,627.00 |
| Jun 30, 2025 | 74,869.00 |
| Mar 31, 2025 | 82,469.00 |
| Dec 31, 2024 | 81,328.00 |
| Sep 30, 2024 | 114,202.00 |
| Jun 30, 2024 | 115,610.00 |
| Mar 31, 2024 | 203,999.00 |
| Dec 31, 2023 | 110,258.00 |
| Sep 30, 2023 | 268,498.00 |
| Jun 30, 2023 | 117,979.00 |
| Mar 31, 2023 | 102,774.00 |
| Dec 31, 2022 | 77,697.00 |
| Sep 30, 2022 | 87,269.00 |
| Jun 30, 2022 | 89,935.00 |
| Mar 31, 2022 | 71,788.00 |
| Dec 31, 2021 | 58,792.00 |
| Sep 30, 2021 | 72,805.00 |
| Jun 30, 2021 | 54,034.00 |